A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer
Condition: Metastatic Castration-Resistant Prostate Cancer · Sponsor: Hoffmann-La Roche
About this study
This study will evaluate the efficacy and safety of the combination of inavolisib plus enzalutamide compared with physician's choice of alternative androgen receptor pathway inhibitor (ARPi) or docetaxel in biomarker-selected participants with metastatic castrate-resistant prostate cancer (mCRPC) who have received one prior second-generation ARPi.
This description comes directly from the study's public registry record.
Talk to the study team
Reference Study ID Number: CO45813 https://forpatients.roche.com/ No attachments to email below. · 888-662-6728 (U.S. and Canada) · global-roche-genentech-trials@gene.com
Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry
Always discuss trial participation with your own doctor first.
Locations (47)
| VA West Los Angeles Medical Center - (CRS) - NAVREF - PPDS | Los Angeles, California, United States | Recruiting |
| UCSF | San Francisco, California, United States | Recruiting |
| Holden Comprehensive Cancer Center | Iowa City, Iowa, United States | Recruiting |
| Montefiore Einstein Cancer Center | The Bronx, New York, United States | Recruiting |
| Lifespan Cancer Institute | Providence, Rhode Island, United States | Recruiting |
| Carolina Urologic Research Center | Myrtle Beach, South Carolina, United States | Recruiting |
| Royal North Shore Hospital-Pacific Hwy | St Leonards, New South Wales, Australia | Recruiting |
| Sunshine Coast University Hospital | Birtinya, Queensland, Australia | Recruiting |
| Royal Brisbane & Womens Hospital | Herston, Queensland, Australia | Recruiting |
| Box Hill Hospital | Box Hill, Victoria, Australia | Recruiting |
| Irmandade Da Santa Casa de Misericordia de Porto Alegre | Porto Alegre, Rio Grande do Sul, Brazil | Recruiting |
| CEPHO - Centro de Estudos e Pesquisas em Hematologia e Oncologia | Santo André, São Paulo, Brazil | Recruiting |
+ 35 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07287150